Myrbetriq (mirabegron) is a prescription medication used in adults to manage overactive bladder (OAB), a condition characterized by urgency, increased frequency of urination, and urge-related leakage.
Unlike traditional antimuscarinic therapies, Myrbetriq works through a β3-adrenergic pathway, helping relax the bladder’s smooth muscle during the storage phase. This allows the bladder to hold more urine and reduces sudden, uncontrollable urges.
OAB is a common and often underreported condition that can significantly impact daily activities, sleep, and quality of life. With appropriate treatment, including medications like Myrbetriq and lifestyle modifications, patients can achieve better symptom control and improved confidence in managing their condition.
Myrbetriq is typically taken once daily as an extended-release tablet and may be used alone or in combination with other therapies, depending on patient needs and physician guidance.
